If you haven’t already done so, please join ORSZCA, the open global network to accelerate the adoption of the new WHO recommendation for diarrhoea treatment: co-packaged ORS and Zinc. Please also follow us on Twitter: @ORSZCA. Supporting the ORSZCA global alliance will lead ColaLife to achieve the final phase of our global impact strategy. ORSZCA […]
The role of innovation in augmenting Healthcare – the ColaLife Story
29 November 2019 by
I have spent the last two days (27 to 28-Nov-19) at the Africa Health Extension Summit (#AHES19) in Nairobi where I told an abbreviated version of the ColaLife story to illustrate the role of innovation in improving healthcare. Key themes were: why we need innovation in the healthcare sector what we mean by innovation how […]
Success: WHO adds co-packaged ORS and Zinc to its Essential Medicines List
9 July 2019 by
Our application* to get co-packaged ORS and zinc on the WHO Essential Medicines List has been successful. This is game-changer. It moves ColaLife’s work out of the ‘innovation box’ into the mainstream of global children’s public health – with better designed, easier-to-dispense diarrhoea treatment available for sick children – potentially everywhere. A summary of the […]
MSF writes letter of support for our application to get co-packaged ORS and zinc on the WHO Essential Medicines List
16 May 2019 by
It was drawn to my attention just yesterday (15-May-19) that MSF (Médecins Sans Frontières) wrote a strong letter of support for our application to get co-packaged ORS and zinc on the WHO Essential Medicines List. I approached MSF, like others, before we lodged the application but they declined saying that they would assess the application […]
Our EML application now open for comments on the WHO website
31 January 2019 by
[20-Mar-2023 Addendum: the links below to the WHO website no longer work. Our application can now be downloaded here. The summary of the WHO Secretariat’s decision to include co-packaged ORS and zinc is available here.] Our application to get co-packaged ORS and zinc on the WHO Model Essential Medicines List for Children (EMLc) is now […]
Top 10 achievements in 2018
30 December 2018 by
2009’s top 10 | 2010’s top 10 | 2011’s top 10 | 2012’s top 10 | 2013’s top 10 2014’s top 10 | 2015’s top 10 | 2016’s top 10 | 2017’s top 10 2018 saw us move from self-sustaining development in Zambia towards the globalisation of our work. The cover page of our application to the World Health […]
DfID Secretary of State and UNICEF provide letters of support
25 November 2018 by
On 12-Nov-18 we submitted our application to WHO to add co-packaged ORS and zinc to the WHO Essential Medicines List for Children and this was reported here. Our application was submitted with ten letters of support. The application and the letters of support are now available on the WHO website here. Letters of support have […]
Update 2: Co-packaged ORS/Zinc on the WHO Essential Medicines List for Children (EMLc)
27 July 2018 by
We met with WHO representatives on 25-Jun-18 in Geneva to discuss our application It’s a year since I last updated you on our progress towards getting co-packaged ORS and zinc on WHO’s Essential Medicines List for Children (EML). You can read the last update here. In summary, a lot of progress has been made and […]
Update: Co-packaged ORS/Zinc on the WHO Essential Medicines List for Children (EMLc)
7 June 2017 by
As reported earlier, we are working to get co-packaged ORS and Zinc on WHO’s Essential Medicines List for Children (EMLc). We are doing this because the circumstantial evidence suggests that while ORS and Zinc are listed separately on the EMLc they will be procured and supplied separately and rarely dispensed together. The combined use of […]
Making the Case for Inclusion of Co-packaged ORS/Zinc on the WHO Model List of Essential Medicines for Children (EMLc)
27 March 2017 by
The WHO Model List of Essential Medicines For four decades, the World Health Organisation (WHO) has devoted substantial effort to an essential medicines programme that seeks to improve access to the most needed drugs and devices. The meeting of the 21st WHO Expert Committee on the Selection and Use of Essential Medicines will be held […]
